Character size
连发注册送28登入
M
L
JPN
ENG
Contact Us
About Kaken
About Kaken TOP
Company Profile
Corporate Governance
History
Compliance
Environmental Initiatives
Map
Business
Business TOP
Pharmaceuticals and Medical Devices
Agrochemicals and Animal Health Products
Overseas Activity
Research & Development Division
Licensing Opportunities
Investor Relations
Investor Relations TOP
Consolidated Earnings Briefing
Consolidated Financial Results
Corporate Report
Shareholders' Meeting
Disclosure Policy
Press Release
About Kaken
Business
Investor Relations
Press Release
View All
January 13, 2021
License and Co-Development Agreement for a novel multispecific antibody candidate
November 18, 2020
The NHI Drug Reimbursement Price Listing and Launch of ECCLOCK? Gel 5% for the Treatment of Primary Axillary Hyperhidrosis
September 25, 2020
ECCLOCK? Gel 5% Approved in Japan for the Treatment of Primary Axillary Hyperhidrosis
September 14, 2020
Approval for sales of Jublia? in Macau
网站地图
澳门新威尼斯人注册送38登入
同升国际注册送68登入
米博国际注册送18登入
申博会员网址
菲律宾申博代理开户合作
申博太阳城娱乐cc
太阳城注册
盛大游戏客户端下载
申博亚洲客户端
菲律宾申博太阳城代理网址
利发国际永发厅gp真人
163A彩票注册送163登入
88大宝注册送8.88元登入
百乐宫注册送38登入
大西洋注册送38元登入
捕鱼注册送29登入
金沙娱乐注册送55登入
澳门新葡京注册送18登入
大班BET注册送18元登入
958XTD.COM
600xsb.com
288TGP.COM
1112936.COM
999TGP.COM
23jbs.com
957SUN.COM
XSB587.COM
66sbmsc.com
8TFS.COM
8888XSB.COM
XSB687.COM
451xx.com
1112936.COM
1112937.COM
173XTD.COM
698XTD.COM
86XTD.COM
38XTD.COM
307SUN.COM